Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 7% | |
| epithelial cell | 4 studies | 23% ± 6% | |
| macrophage | 4 studies | 18% ± 2% | |
| astrocyte | 4 studies | 26% ± 6% | |
| glutamatergic neuron | 4 studies | 33% ± 16% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| microglial cell | 3 studies | 20% ± 2% | |
| transit amplifying cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1281.83 | 1444 / 1445 | 100% | 13.87 | 183 / 183 |
| lung | 99% | 1162.28 | 575 / 578 | 99% | 8.85 | 1145 / 1155 |
| breast | 100% | 1372.29 | 459 / 459 | 98% | 12.66 | 1094 / 1118 |
| brain | 99% | 901.65 | 2624 / 2642 | 98% | 9.13 | 692 / 705 |
| intestine | 100% | 1553.03 | 966 / 966 | 96% | 7.27 | 506 / 527 |
| stomach | 100% | 904.80 | 359 / 359 | 95% | 8.73 | 273 / 286 |
| uterus | 100% | 1653.97 | 170 / 170 | 95% | 10.87 | 438 / 459 |
| bladder | 100% | 1385.19 | 21 / 21 | 94% | 7.51 | 476 / 504 |
| thymus | 100% | 1351.52 | 653 / 653 | 94% | 7.31 | 571 / 605 |
| ovary | 100% | 1328.67 | 180 / 180 | 94% | 6.04 | 405 / 430 |
| pancreas | 98% | 651.02 | 323 / 328 | 95% | 5.77 | 169 / 178 |
| prostate | 100% | 1208.06 | 245 / 245 | 89% | 6.30 | 446 / 502 |
| kidney | 100% | 794.03 | 89 / 89 | 87% | 5.18 | 780 / 901 |
| adrenal gland | 100% | 887.47 | 257 / 258 | 87% | 4.64 | 199 / 230 |
| skin | 100% | 1321.10 | 1805 / 1809 | 82% | 6.99 | 388 / 472 |
| liver | 99% | 475.85 | 223 / 226 | 61% | 2.64 | 247 / 406 |
| blood vessel | 100% | 1478.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1293.62 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1363.65 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1070.29 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 771.40 | 836 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 11.22 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 6.31 | 21 / 29 |
| peripheral blood | 55% | 750.82 | 512 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 35% | 1.55 | 28 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0097190 | Biological process | apoptotic signaling pathway |
| GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
| GO_0071260 | Biological process | cellular response to mechanical stimulus |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0036337 | Biological process | Fas signaling pathway |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016605 | Cellular component | PML body |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0005123 | Molecular function | death receptor binding |
| GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
| GO_0016505 | Molecular function | peptidase activator activity involved in apoptotic process |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0032184 | Molecular function | SUMO polymer binding |
| Gene name | CASP8AP2 |
| Protein name | CASP8-associated protein 2 (FLICE-associated huge protein) CASP8AP2 protein Alternative protein CASP8AP2 Caspase 8 associated protein 2 |
| Synonyms | RIP25 FLASH KIAA1315 |
| Description | FUNCTION: Participates in TNF-alpha-induced blockade of glucocorticoid receptor (GR) transactivation at the nuclear receptor coactivator level, upstream and independently of NF-kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of GR transactivation. Involved in TNF-alpha-induced activation of NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream mediator for CASP8-induced activation of NF-kappa-B. Required for the activation of CASP8 in FAS-mediated apoptosis. Required for histone gene transcription and progression through S phase. . |
| Accessions | A0A087WTW5 Q9UKL3 ENST00000671703.2 ENST00000419040.6 L8EC81 ENST00000552401.5 ENST00000551025.4 A0A096LP21 A7E2C0 |